Because of their small size, nanoscale devices can readily interact with biomolecules on both the surface and the inside of cells. By gaining access to so many areas of the body, they have the potential to detect disease and deliver treatment in unique ways. Nanotechnology will help in the creation of “smart drugs” that are more targeted and have fewer side effects than traditional drugs.
Current applications of nanotechnology in health care include drug delivery (in immunosuppressants, hormone therapies, drugs for cholesterol control, and drugs for appetite enhancement) as well as advances in imaging, diagnostics and bone replacement. For example, the NanoCrystal technology developed by Elan, a major biotechnology company, enhances drug delivery in the form of tiny particles, typically less than 2,000 nanometers in diameter. The technology can be used to provide more effective delivery of drugs in tablet form, capsules, powders and liquid dispersions. Abbott Laboratories used Elan’s technology to improve results in its cholesterol drug TriCor. Par Pharmaceutical Companies uses NanoCrystal in its Megace ES drug for the improvement of appetite in people with anorexia.
Since biological processes, including events that lead to cancer, occur at the nanoscale at and inside cells, nanotechnology offers a wealth of tools that are providing cancer researchers with new and innovative ways to diagnose and treat cancer. In America, the National Cancer Institute has established the Alliance for Nanotechnology in Cancer (http://nano.cancer.gov ) in order to foster breakthrough research.
Nanoscale devices have the potential to radically change cancer therapy for the better and to dramatically increase the number of effective therapeutic agents. These devices can serve as customizable, targeted drug delivery vehicles capable of ferrying large doses of chemotherapeutic agents or therapeutic genes into malignant cells while sparing healthy cells, greatly reducing or eliminating the often unpalatable side effects that accompany many current cancer therapies.
At the University of Michigan at Ann Arbor, Dr. James Baker is working with molecules known as dendrimers to create new cancer diagnostics and therapies, thanks to grants from the National Institutes of Health and other funds. This is part of a major effort named the Michigan Nanotechnology Institute for Medicine and Biological Sciences. In 2014, Merck & Co. subsidiary NanoBio Corporation licensed the use of a nanoeumlsion adjuvant technology developed at the Institute.
A dendrimer is a spherical molecule of uniform size (five to 100 nanometers) and well-defined chemical structure. Dr. Baker’s lab is able to build a nanodevice with four or five attached dendrimers. To deliver cancer-fighting drugs directly to cancer cells, Dr. Baker loads some dendrimers on the device with folic acid, while loading others with drugs that fight cancer. Since folic acid is a vitamin, many proteins in the body will bind with it, including proteins on cancer cells. When a cancer cell binds to and absorbs the folic acid on the nanodevice, it also absorbs the anticancer drug. For use in diagnostics, Dr. Baker is able to load a dendrimer with molecules that are visible to an MRI. When the dendrimer, due to its folic acid, binds with a cancer cell, the location of that cancer cell is shown on the MRI. Each of these nanodevices may be developed to the point that they are able to perform several advanced functions at once, including cancer cell recognition, drug delivery, diagnosis of the cause of a cancer cell, cancer cell location information and reporting of cancer cell death. Universities that are working on the leading edge of cancer drug delivery and diagnostics using nanotechnology include MIT and Harvard, as well as Rice University and the University of Michigan.
Meanwhile, at the University of Washington, a research group led by Babak A. Parviz has investigated manufacturing methods that resemble that of plants and other natural organisms by “self-assembly.” If man-made machines could be designed to assemble themselves, it could revolutionize manufacturing, especially on the nanoscale level. Researchers are studying ways to program the assembly process by sparking chemical synthesis of nanoscale parts such as quantum dots or molecules which then bind to other parts through DNA hybridization or protein interactions. The group led by Professor Parviz is attempting to produce self-assembled high-performance silicon circuits on plastic. It is conceivable that integrated circuits, biomedical sensors or displays could be “grown” at rates exponentially faster than current processes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Become a Plunkett Research Online subscriber to gain unlimited access to our massive amount of vital industry data and market research.
- ✔ 100,000 Industry Statistics
- ✔ 500 Industries Analyzed for Market Size, Profits and Forecasts
- ✔ 150,000 Industry Executives Profiled
- ✔ 25,000 Companies Profiled, Ranked and Analyzed
- ✔ 1,000 Vital Trends Analyzed, totaling 1,000,000 words
A Representative List of Organizations that Have Used our Research and Products:
